Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized comparison of oral budesonide vs oral mesalazine in moderately active Crohn's disease
2004-001213-34Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Nov 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Budesonide arm with Mesalazine arm (2 arms). Started Nov 2004; status: completed.
02
Drugs
budesonideSalcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2004-001213-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001213-34.